Document is current
Any future updates will be listed below
-
Authors
Wahid, Rahnuma https://orcid.org/0000-0001-9344-7685
Mercer, Laina https://orcid.org/0000-0002-2517-8900
Gast, Chris
De Leon, Tirza
Sáez-Llorens, Xavier
Fix, Alan https://orcid.org/0000-0003-2912-6267
Macadam, Andrew https://orcid.org/0000-0002-8687-1573
Stephens, Laura
Chumakov, Konstantin https://orcid.org/0000-0003-3002-6247
Smits, Saskia L.
Murreddu, Marta
Konopka-Anstadt, Jennifer L.
Steven Oberste, M.
Burns, Cara C. https://orcid.org/0000-0003-2582-2476
Andino, Raul
Bachtiar, Novilia Sjafri
Tritama, Erman
Bandyopadhyay, Ananda S.
Aguirre, Gabriela
Rüttimann, Ricardo
Konz, John O. https://orcid.org/0000-0001-8309-5540
-
Funding
Funding for this research was provided by:
Bill and Melinda Gates Foundation (OPP1150001, OPP1150001, OPP1150001, OPP1150001, OPP1150001, OPP1150001, OPP1150001)
Bill and Melinda Gates Foundation
Bill and Melinda Gates Foundation
Bill and Melinda Gates Foundation
Bill and Melinda Gates Foundation
Bill and Melinda Gates Foundation
Bill and Melinda Gates Foundation
- License Information
-
More Information
Article History
Received: 20 May 2021
Accepted: 16 December 2021
First Online: 11 February 2022
Competing interests
: NIBSC and CDC claim intellectual property rights associated with the candidates. E.T. and N.S.B. work for the manufacturer of nOPV2. The remaining authors declare no competing interests.
